本页面由Tiger Trade Technology Pte. Ltd.提供服务

美第奇新星生物技术

1.41
0.0000
成交量:7.14万
成交额:10.03万
市值:6,929.62万
市盈率:-5.76
高:1.42
开:1.40
低:1.38
收:1.41
52周最高:1.96
52周最低:1.13
股本:4,914.62万
流通股本:4,208.10万
量比:0.71
换手率:0.17%
股息:- -
股息率:- -
每股收益(TTM):-0.2449
每股收益(LYR):-0.2445
净资产收益率:-25.50%
总资产收益率:-16.36%
市净率:1.67
市盈率(LYR):-5.77

数据加载中...

2026/02/20

重要事件披露

Form 8-K - Current report
2025/12/30

重要事件披露

Form 8-K - Current report
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/09/26

SEC问询函

Form CORRESP - Correspondence
2025/08/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/01

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments